BridgeMD
New treatment option for Apraxia of Speech
Official title Using tDCS in Speech-based Stroke Rehabilitation
ClinicalTrials.gov ID: NCT03452202
What this study is testing
- What it's testing
- The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Right-handed
- Monolingual (English)
- Single left-hemisphere CVA
- A minimum of six months post-stroke
- Clinical diagnosis of apraxia of speech
You likely can't join if
- Diagnosis of laryngeal voice disorder
- Dysarthria
- History of speech impairment prior to CVA
- Presence of potential tDCS risk factors: damaged skin at site of stimulation;
- Presence of electrically or magnetically activated implant (including pacemaker);
- metal in any part of their body;
See the full eligibility criteria
- Right-handed
- Monolingual (English)
- Single left-hemisphere CVA
- A minimum of six months post-stroke
- Clinical diagnosis of apraxia of speech
- Normal speech perception
- Passing score on the hearing screening.
- Diagnosis of laryngeal voice disorder
- Dysarthria
- History of speech impairment prior to CVA
- Presence of potential tDCS risk factors: damaged skin at site of stimulation;
- Presence of electrically or magnetically activated implant (including pacemaker);
- metal in any part of their body;
- history of medication-resistant epilepsy in the family;
- past history of seizures or unexplained spells of loss of consciousness.
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
- White Plains, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States; White Plains, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.